A Phase IIa Study to Evaluate the Efficacy and Safety of 6MW3211 in Patients With Advanced Lung Cancer
Clinical trial NCT05431569 · UNKNOWN
Trial details
- NCT number
- NCT05431569
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-10
- Primary completion
- 2022-12-10
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.